Immuno-Oncology Forum

26-27 June 2023 | Stockholm

Following the success of the Nordic Precision Medicine Forum we are thrilled to announce the inaugural Nordic Oncology Forum, a multi topic meeting dedicated to advancing the diagnosis, prognosis and treatment of cancer in and across the Nordics.

In recent years immunotherapies have emerged as a new standard of care in the treatment of a wide variety of malignancies. With numerous therapeutic modalities and mechanistic approaches being developed from immune modulation to multi-specific antibodies, to cancer vaccines and cell-based approaches, all empowering the immune system to prevent, control, and eliminate cancer. The Immuno-Oncology Forum will address such promising immunotherapies, how they are performing in the clinic and how they can be combined with precision medicine approaches to further increase the standard of care.


The agenda for 2023 is currently in production and will be released soon. To be informed when it is available, please contact us.


From keynotes to panel discussions, industry satellites to posters, speaking at our Forum puts you in front of the right people. Speaking opportunities are limited so if you feel you have something you can bring to the table please contact us.


The foundation, and we believe the success of our events, lies in the preparation. Extensive research, engagement with industry leaders and targeted marketing campaigns ensure that we produce timely, relevant programmes, and bring the right people together.

Our Speakers

Speakers for Precision Oncology Forum comprises C-Level multidisciplinary group of experts drawn from healthcare, industry, patient groups, research, payers and Government. The programme is currently in production. We will be releasing the confirmed speakers soon and a full agenda in early 2023.

Contact Joel Hornby


Jon A Kyte MD PhD

Head, Department of Clinical Cancer Research, Research Group Leader, Department of Cancer Immunology, Oslo University Hospital


Mathias Uhlen

Founding Director of the Science for Life Laboratory (SciLifeLab), a Swedish national center for molecular bioscience.


Luca Gattinoni

Director, Division of Functional Immune Cell Modulation, Leibniz Institute of Immunotherapy, Regensburg, Germany

Scroll to Top